STVN logo

STVN Stevanato Group S.p.A.

New York Stock Exchange · Medical - Instruments & Supplies · Healthcare

$15.65
-0.28 (-1.76%)

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual ins…

Market Cap: $4.27Bwww.stevanatogroup.com

Price

$20.27+14.46%
$16.51$17.87$19.23$20.59
May 1Aug 7

Social Signal Score

39
5d
—
30d
40
7 mentions
+0.0%
60d
36
8 mentions
+0.0%
90d
39
10 mentions
+0.0%
news: 10

Analyst Ratings

9 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 4Sell 0Strong Sell 0
Avg price target$24.5+56.5%
Low $17.5Median $24High $32
Current Consensus

Revenue

$324.16M+137.60%
$136.43M$205.37M$274.31M$343.25M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$0.53
$0.52–$0.53
8 analysts
FY2026
$0.59+13% YoY
$0.54–$0.62
8 analysts
FY2027
$0.64+7% YoY
$0.60–$0.66
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Franco Stevanato
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
6,010
Beta
0.80
Country
IT
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.64
www.stevanatogroup.com